J&J offers few details on headcount, HQ following $16.6B Abiomed acquisition


Johnson & Johnson Inc. is offering few details yet about the future of Abiomed's Massachusetts footprint once its acquisition of the medical device maker closes in early 2023. Here's what we know.

Previous Dentsply Sirona internal probe finds no 'intentional fraud' — but flags China violations
Next Journal Profile: Where fashion designer Kate Falchi finds inspiration — and what she thinks of Austin's style